Updated: 223 Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experience

Abstract

Get full access to this article

View all access options for this article.

References

Boni

Mazzarri

Cianci

et al . ²²³Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: real-world experience. Tumori 2018; 104: 128–136.

European Medical Authority. EMA Assessment Report on Provisional Measures: procedure under Article 20 of Regulation (EC) 726/2004 resulting from pharmacovigilance data. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/002653/WC500246181.pdf.